Company News

Galderma Enters Nutraceuticals Market

Author Image

By: TOM BRANNA

Editor

Galderma is entering the nutraceutical market through the acquisition of certain assets of Inneov Group, including Nutri-Care D, Duocap, Densilogy, Densilogy Men, Fermete, Fermete Aox, Firmness, Pre-Hyaluron 465, Solar and Sun Sensitivity products. “The nutraceutical category has a strong fit with our self-medication business. Many of the Innéov brands are complementary to our existing portfolio of skin health medical solutions,” said Stuart Raetzman, CEO of Galderma. “We look forward to expa...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters